Genetic Breast & Ovarian Cancer Risk
A genetic test that looks for variants in 10 genes associated with inherited breast and ovarian cancer risk.
Results usually available within 4-6 weeks after the laboratory receives your sample
What does it check?
- BRCA1 and BRCA2 genes
- PALB2, CHEK2, ATM genes
- TP53, PTEN, CDH1, STK11 genes
- BARD1, RAD51C, RAD51D genes
Who may benefit?
Individuals with a family history of breast cancer (especially before age 50 or in multiple relatives), ovarian cancer, male breast cancer, or Ashkenazi Jewish heritage.
Genetic Breast & Ovarian Cancer Risk
SMITHS
Medical Group
What is it?
A genetic test that looks for variants in 10 genes associated with inherited breast and ovarian cancer risk.
Who may benefit?
Individuals with a family history of breast cancer (especially before age 50 or in multiple relatives), ovarian cancer, male breast cancer, or Ashkenazi Jewish heritage.
Comprehensive gene panel
BRCA1 and BRCA2 genes
PALB2, CHEK2, ATM genes
TP53, PTEN, CDH1, STK11 genes
BARD1, RAD51C, RAD51D genes
Important information
Genetic counselling is provided with this test. Identifying a pathogenic mutation enables personalised screening (e.g. early MRI/mammography) and preventative risk-reduction strategies.